Bischofsheim, Germany

Heinz-Werner Kleeman


Average Co-Inventor Count = 2.4

ph-index = 2

Forward Citations = 62(Granted Patents)


Location History:

  • Kelsterbach, DE (1992)
  • Bad Homburg, DE (1997)
  • Bischofsheim, DE (2003 - 2008)

Company Filing History:


Years Active: 1992-2008

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Heinz-Werner Kleeman

Introduction

Heinz-Werner Kleeman is a notable inventor based in Bischofsheim, Germany. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative patents. With a total of 4 patents to his name, Kleeman's work has had a considerable impact on the development of new therapeutic agents.

Latest Patents

Kleeman's latest patents include the invention of pentafluorosulfanylphenyl-substituted benzoylguanidines. This invention details a method for the production of these compounds, which are used as medicaments or diagnostic agents. The patent outlines a process for preparing compounds of a specific formula and their pharmaceutically acceptable salts. Additionally, he has developed substituted 1-naphthoylguanidines, along with a process for their preparation and their application as medicaments or diagnostic agents.

Career Highlights

Throughout his career, Kleeman has worked with prominent companies in the pharmaceutical industry, including Hoechst Aktiengesellschaft and Aventis Pharma Deutschland GmbH. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.

Collaborations

Kleeman has collaborated with several notable colleagues, including Udo Albus and Hansjorg Urbach. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Heinz-Werner Kleeman's contributions to medicinal chemistry through his patents demonstrate his innovative spirit and dedication to improving healthcare. His work continues to influence the field and pave the way for future advancements in medicinal compounds.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…